Pierre Sayad
Förmögenhet: 208 679 $ per 2026-05-31
Förmögenhet: 208 679 $ per 2026-05-31
Pierre S.
Sayad is currently Chief Medical Officer at Fennec Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Sayad was Senior Vice President-Global Medical Affairs at International Myeloma Foundation, Vice President-Global Medical & Scientific Affairs at Karyopharm Therapeutics, Inc., and Chief Operating & Medical Officer at Zephyr Group, Inc. Education includes graduate studies at Loma Linda University and undergraduate studies at San Jose State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-01 | 21 015 ( 0,06 % ) | 208 679 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-10-28 |
| Företag | Position | Slut |
|---|---|---|
International Myeloma Foundation
International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Företagsledare/Principal | - |
| KARYOPHARM THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Fennec Pharmaceuticals, Inc.
Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
International Myeloma Foundation
International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Commercial Services |
Loma Linda University
Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån